Fulgent Genetics, Inc.
Price Action
Technical Summary
CONSOLIDATINGFulgent Genetics, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 55), indicating performance broadly in line with the market. Earnings contraction of 116% provides fundamental context to the price action. However, with RSI at 75, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $19.25 | +9.22% | ABOVE |
| 50 SMA | $17.60 | +19.44% | ABOVE |
| 100 SMA | $17.41 | +20.73% | ABOVE |
| 150 SMA | $20.61 | +1.97% | ABOVE |
| 200 SMA | $21.60 | -2.68% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is FLGT in an uptrend right now?
FLGT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is FLGT overbought or oversold?
FLGT's RSI (14) is 75. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is FLGT outperforming the market?
FLGT has a Relative Strength (RS) Rating of 55 out of 99. FLGT is performing about average compared to the market.
Where is FLGT in its 52-week range?
FLGT is trading at $21.02, which is 68% of its 52-week high ($31.04) and 43% above its 52-week low ($13.46).
How volatile is FLGT?
FLGT has a Beta of 0.67 and 52-week volatility of 58%. It's less volatile than the S&P 500 - generally more stable.